Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Dexmedetomidine market size was valued at USD 1190.91 million in 2022 and is expected to expand at a CAGR of 14.34% during the forecast period, reaching USD 2661.15 million by 2028.
Dexmedetomidine is a sedative, which is used to inject sedatives into patients who are receiving intensive medical care and need mechanical ventilators. Dexmedetomidine is also used during anesthesia to prepare patients for surgery or other medical procedures.
To standardize the clinical diagnosis and treatment of severe and critical COVID-19 (covid-19), improve the success rate of treatment and reduce the mortality rate. Critically ill patients are defined as those who have one of the following symptoms: respiratory failure and need mechanical ventilation, shock, and other organ failure and need to be admitted to intensive care unit (ICU). At present, the most common causes of death of critically ill patients in Covid-19 are respiratory failure and multiple organ failure caused by intractable hypoxia. Analgesia and sedation, as an important part of ICU patients' treatment, can reduce the metabolic rate of patients, reduce their oxygen consumption, reduce the metabolic burden of various organs, and create conditions for the recovery of organ functions. Dexmedetomidine is a commonly used sedative in critically ill patients, and the epidemic situation may affect the fluctuation of demand for dexmedetomidine.
In order to curb the COVID-19 epidemic, most countries have introduced many policies, including border blockade and social distancing. The epidemic prevention and control measures will affect the flow of people and activities, and in turn affect logistics, making the production of manufacturing, especially labor-intensive industries, affected by the supply of raw materials and labor shortages.
Economic Factors
Economic factors have a significant impact on how an organization does business and also how profitable they are. Factors include-economic growth, interest rates, exchange rates, inflation, disposable income of consumers and businesses, and so on.
These factors can be further broken down into macro-economic and micro-economic factors. Macro-economic factors deal with the management of demand in any given economy. Governments use interest rate control, taxation policy, and government expenditure as the main mechanisms they use for this.
Technological Factors
The improvement of drug adaptation rate and disease awareness, as well as the increasing attention to the discovery of other uses of Dexmedetomidine in health care, are promoting the growth of the market of Dexmedetomidine. Changes in technical factors will provide new manufacturing methods for Dexmedetomidine industries, affect manufacturing costs of enterprises, and provide new opportunities for enterprises to develop new products.
Environmental Factors
Harmful substances such as waste water, waste gas and waste residue will be produced in the process of pharmaceutical production, thus causing pollution to the environment. With the introduction of new environmental protection standards for pharmaceutical industry and national environmental protection standards in various countries and regions, the environmental protection cost of factory production has been increasing, which has greatly increased the management cost of the company and caused certain capital pressure. If the company's emissions in the production process fail to meet the standards, the company will be subject to corresponding penalties, which will inevitably cause adverse effects on the company's normal production and operation.
Region Overview:
In 2021, the share of the Dexmedetomidine market in North America stood at 41.38%.
Company Overview:
Pfizer Inc. is one of the major players operating in the Dexmedetomidine market, holding a share of 33.34% in 2021.
Pfizer Inc.
Pfizer Inc. is an American multinational pharmaceutical corporation. Pfizer is one of the world's largest pharmaceutical companies. Headquartered in Manhattan, Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology.
Yangtze River Pharmaceutical Group
Yangtze river pharmaceutical group, founded in 1971, is the first batch of innovative enterprises in China named by the Ministry of science and technology. Headquartered in Taizhou City, Jiangsu Province, the Group has more than 16,000 employees.
Segmentation Overview:
By type, 0.1 mg / mL segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Intensive Care Unit Sedation segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Dexmedetomidine industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Dexmedetomidine. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Dexmedetomidine Market Report Include:
Market Size Estimates: Dexmedetomidine market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Dexmedetomidine market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Dexmedetomidine market
Segment Market Analysis: Dexmedetomidine market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Dexmedetomidine market situations and prospects in major and top regions and countries
Dexmedetomidine Market
Dexmedetomidine Industry Chain: Dexmedetomidine market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Dexmedetomidine Industry News, Policies by regions
Dexmedetomidine Industry Porters Five Forces Analysis
Key players in the global Dexmedetomidine market are covered in Chapter 2:
Accord Healthcare
Yangtze River Pharmaceutical Group
Mylan
Jiangsu Hengrui Medicine Co.,Ltd.
Orion Pharma
Pfizer Inc.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
EVER NEURO PHARMA GMBH
In Chapter 6 and Chapter 9, on the basis of types, the Dexmedetomidine market from 2018 to 2028 is primarily split into:
0.004mg / mL
0.1 mg / mL
0.5 mg / mL
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Dexmedetomidine market from 2018 to 2028 covers:
Intensive Care Unit Sedation
Procedural Sedation
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Dexmedetomidine market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Dexmedetomidine industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Dexmedetomidine market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Dexmedetomidine industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Dexmedetomidine market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Dexmedetomidine market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Dexmedetomidine market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Dexmedetomidine is a sedative, which is used to inject sedatives into patients who are receiving intensive medical care and need mechanical ventilators. Dexmedetomidine is also used during anesthesia to prepare patients for surgery or other medical procedures.
To standardize the clinical diagnosis and treatment of severe and critical COVID-19 (covid-19), improve the success rate of treatment and reduce the mortality rate. Critically ill patients are defined as those who have one of the following symptoms: respiratory failure and need mechanical ventilation, shock, and other organ failure and need to be admitted to intensive care unit (ICU). At present, the most common causes of death of critically ill patients in Covid-19 are respiratory failure and multiple organ failure caused by intractable hypoxia. Analgesia and sedation, as an important part of ICU patients' treatment, can reduce the metabolic rate of patients, reduce their oxygen consumption, reduce the metabolic burden of various organs, and create conditions for the recovery of organ functions. Dexmedetomidine is a commonly used sedative in critically ill patients, and the epidemic situation may affect the fluctuation of demand for dexmedetomidine.
In order to curb the COVID-19 epidemic, most countries have introduced many policies, including border blockade and social distancing. The epidemic prevention and control measures will affect the flow of people and activities, and in turn affect logistics, making the production of manufacturing, especially labor-intensive industries, affected by the supply of raw materials and labor shortages.
Economic Factors
Economic factors have a significant impact on how an organization does business and also how profitable they are. Factors include-economic growth, interest rates, exchange rates, inflation, disposable income of consumers and businesses, and so on.
These factors can be further broken down into macro-economic and micro-economic factors. Macro-economic factors deal with the management of demand in any given economy. Governments use interest rate control, taxation policy, and government expenditure as the main mechanisms they use for this.
Technological Factors
The improvement of drug adaptation rate and disease awareness, as well as the increasing attention to the discovery of other uses of Dexmedetomidine in health care, are promoting the growth of the market of Dexmedetomidine. Changes in technical factors will provide new manufacturing methods for Dexmedetomidine industries, affect manufacturing costs of enterprises, and provide new opportunities for enterprises to develop new products.
Environmental Factors
Harmful substances such as waste water, waste gas and waste residue will be produced in the process of pharmaceutical production, thus causing pollution to the environment. With the introduction of new environmental protection standards for pharmaceutical industry and national environmental protection standards in various countries and regions, the environmental protection cost of factory production has been increasing, which has greatly increased the management cost of the company and caused certain capital pressure. If the company's emissions in the production process fail to meet the standards, the company will be subject to corresponding penalties, which will inevitably cause adverse effects on the company's normal production and operation.
Region Overview:
In 2021, the share of the Dexmedetomidine market in North America stood at 41.38%.
Company Overview:
Pfizer Inc. is one of the major players operating in the Dexmedetomidine market, holding a share of 33.34% in 2021.
Pfizer Inc.
Pfizer Inc. is an American multinational pharmaceutical corporation. Pfizer is one of the world's largest pharmaceutical companies. Headquartered in Manhattan, Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology.
Yangtze River Pharmaceutical Group
Yangtze river pharmaceutical group, founded in 1971, is the first batch of innovative enterprises in China named by the Ministry of science and technology. Headquartered in Taizhou City, Jiangsu Province, the Group has more than 16,000 employees.
Segmentation Overview:
By type, 0.1 mg / mL segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Intensive Care Unit Sedation segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Dexmedetomidine industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Dexmedetomidine. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Dexmedetomidine Market Report Include:
Market Size Estimates: Dexmedetomidine market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Dexmedetomidine market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Dexmedetomidine market
Segment Market Analysis: Dexmedetomidine market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Dexmedetomidine market situations and prospects in major and top regions and countries
Dexmedetomidine Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Dexmedetomidine Industry Chain: Dexmedetomidine market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Dexmedetomidine Industry News, Policies by regions
Dexmedetomidine Industry Porters Five Forces Analysis
Key players in the global Dexmedetomidine market are covered in Chapter 2:
Accord Healthcare
Yangtze River Pharmaceutical Group
Mylan
Jiangsu Hengrui Medicine Co.,Ltd.
Orion Pharma
Pfizer Inc.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
EVER NEURO PHARMA GMBH
In Chapter 6 and Chapter 9, on the basis of types, the Dexmedetomidine market from 2018 to 2028 is primarily split into:
0.004mg / mL
0.1 mg / mL
0.5 mg / mL
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Dexmedetomidine market from 2018 to 2028 covers:
Intensive Care Unit Sedation
Procedural Sedation
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Dexmedetomidine market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Dexmedetomidine industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Dexmedetomidine market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Dexmedetomidine industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Dexmedetomidine market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Dexmedetomidine market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Dexmedetomidine market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
